Clinical Trial Update: The Pharmacogenetic Study , Readiness to Change, and Pharmacological Intervention for Smoking Cessation in Schizophrenia [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update investigating pharmacogenetics, readiness to change, and pharmacological smoking cessation in individuals with schizophrenia; the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nicotine Dependence
• Schizophrenia

Snippet

Sponsor: Yu-Li Hospital | Conditions: Tobacco Dependence, Schizophrenia | Phase 4 | Status: COMPLETED